COSM
Cosmos Health Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$0.23-1.92%
Price as of Jul 20, 2026
COSM growth
Cosmos Health Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +29.8%
- EBITDA
- -35.4%
- EBIT
- -23.0%
- EPS
- +41.8%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
- Revenue
- +71.4%
- EBITDA
- -5.8%
- EPS
- +104.6%
Three-year CAGR
- Revenue
- +9.0%
- EBITDA
- -8.8%
- EBIT
- -6.4%
- Net income
- -18.3%
- EPS
- +46.2%
- Free cash flow
- -4.5%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.